Gonadal Function in Thalassemic Patient
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age10-18
SponsorSohag University
About this trial
Patient with transfusion depandant beta thalassemia with accumulation of iron in their body affect pituitary gland and gonades lead to impaired their functions .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
transfusion depandant beta thalassemia
age 10 to 18 year old age
Disqualifiers
age below 10 year old age or above 18 year old age
associated with another disease
Trial population
transfusion depandant beta thalassemia male patients age 10 - 18 year old age
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
serum inhibin B serum INSL3 serum AMH
Diagnostic testtransfusion depandant beta thalassemia with measure gonadal function serum INSL3 serum inhibin B serum AMH
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: group 1 transfusion depandant beta thalassemia1 intervention
Trial outcomes
Primary outcomes
1
gonadal function in transfusion depandant beta thalassemia
gonadal function assessment by Inhibin B hormone, INSL3 , serum testesterone that analysed in patient with age 10 - 18 year old for early detection of any abnormality
Time frame
through study completion, an average of 1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: